These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 15731485)
41. Low-density lipoprotein profile changes during the neonatal period. Fujita H; Okada T; Inami I; Makimoto M; Hosono S; Minato M; Takahashi S; Mugishima H; Yamamoto T J Perinatol; 2008 May; 28(5):335-40. PubMed ID: 18337737 [TBL] [Abstract][Full Text] [Related]
42. Prognostic utility of apoB/AI, total cholesterol/HDL, non-HDL cholesterol, or hs-CRP as predictors of clinical risk in patients receiving statin therapy after acute coronary syndromes: results from PROVE IT-TIMI 22. Ray KK; Cannon CP; Cairns R; Morrow DA; Ridker PM; Braunwald E Arterioscler Thromb Vasc Biol; 2009 Mar; 29(3):424-30. PubMed ID: 19122170 [TBL] [Abstract][Full Text] [Related]
43. The mainstream hypothesis that LDL cholesterol drives atherosclerosis may have been falsified by non-invasive imaging of coronary artery plaque burden and progression. Ware WR Med Hypotheses; 2009 Oct; 73(4):596-600. PubMed ID: 19560285 [TBL] [Abstract][Full Text] [Related]
44. [Evaluation of selected risk factors of atherosclerosis in children with type 1 diabetes mellitus and hypercholesterolemia]. Muchacka-Bianga M; Deja G; Jarosz-Chobot P; Małecka-Tendera E; Kalina M; Grychtoł M Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2006; 12(1):25-30. PubMed ID: 16704858 [TBL] [Abstract][Full Text] [Related]
45. Apolipoprotein B: can we continue to ignore? Munigoti SP; Rees A Curr Opin Lipidol; 2010 Feb; 21(1):99-100. PubMed ID: 20101124 [No Abstract] [Full Text] [Related]
46. Interactions of serum hsCRP with apoB, apoB/AI ratio and some components of metabolic syndrome amplify the predictive values for coronary artery disease. Rasouli M; Kiasari AM Clin Biochem; 2006 Oct; 39(10):971-7. PubMed ID: 16963013 [TBL] [Abstract][Full Text] [Related]
47. Small dense low-density lipoprotein in renal transplant recipients: a potential target for prevention of cardiovascular complications? Badiou S; Garrigue V; Dupuy AM; Chong G; Cristol JP; Mourad G Transplant Proc; 2006 Sep; 38(7):2314-6. PubMed ID: 16980076 [TBL] [Abstract][Full Text] [Related]
48. Small LDL, atherogenic dyslipidemia, and the metabolic syndrome. Grundy SM Circulation; 1997 Jan; 95(1):1-4. PubMed ID: 8994405 [No Abstract] [Full Text] [Related]
49. Longevity associated with larger size of cholesterol particles. Mayo Clin Womens Healthsource; 2004 Mar; 8(3):3. PubMed ID: 15001848 [No Abstract] [Full Text] [Related]
52. SYNTAX Score in Patients With Stable Coronary Artery Disease. Ozbay MB; Ozen Y; Yayla Ç Angiology; 2019 Feb; 70(2):186. PubMed ID: 30037289 [No Abstract] [Full Text] [Related]
53. To ApoB or Not to ApoB: New Arguments, but Basis for Widespread Implementation Remains Elusive. Welsh P; Sattar N Clin Chem; 2023 Jan; 69(1):3-5. PubMed ID: 36427190 [No Abstract] [Full Text] [Related]
59. Hypolipidemic effect of Fragarianilgerrensis Schlecht. medicine compound on hyperlipidemic rats. Gao L; Lin Z; Liu Y; Wang X; Wan L; Zhang L; Liu X Lipids Health Dis; 2018 Sep; 17(1):222. PubMed ID: 30231880 [TBL] [Abstract][Full Text] [Related]